These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3827187)

  • 21. Lipoprotein analysis in transgenic mice expressing human apolipoprotein (apo) A-I and apo C III: use of micromethods in analysis of lipoprotein system in mice.
    Ito Y
    Hokkaido Igaku Zasshi; 1994 Mar; 69(2):312-26. PubMed ID: 8157256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men.
    Singh AB; Hsia S; Alaupovic P; Sinha-Hikim I; Woodhouse L; Buchanan TA; Shen R; Bross R; Berman N; Bhasin S
    J Clin Endocrinol Metab; 2002 Jan; 87(1):136-43. PubMed ID: 11788637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum remnant lipoprotein cholesterol/triglyceride ratio as an index for screening familial type III hyperlipidaemia.
    Nakajima K; Daimon M; Kamiyama K; Takanashi K; Suzuki Y; Watanabe M; Kubono K; Saniabadi AR; Takashima S; Sakurabayashi I
    Ann Clin Biochem; 2007 Jul; 44(Pt 4):353-9. PubMed ID: 17663088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gender differences and diabetic status in the relationship of blood apolipoprotein C-III, free fatty acids and triglycerides in subjects at risk for glucose intolerance].
    Flórez H; Méndez AJ; Jones L; Goldberg RB
    Invest Clin; 1999 Mar; 40(1):51-66. PubMed ID: 10198561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunochemical methods for quantification of human apolipoprotein C-III.
    Kashyap ML
    Methods Enzymol; 1996; 263():208-18. PubMed ID: 8749009
    [No Abstract]   [Full Text] [Related]  

  • 26. Apolipoproteins C-II and C-III in peripheral arterial disease.
    Alessandri C; Basili S; Maurelli M; Andreozzi P; Colletta A; Paradiso M; Cordova C
    Angiology; 1994 Feb; 45(2):131-6. PubMed ID: 8129188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients.
    Franceschini G; Sirtori M; Gianfranceschi G; Frosi T; Montanari G; Sirtori CR
    Artery; 1985; 12(6):363-81. PubMed ID: 4051756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of type I hyperlipoproteinemia.
    Gnasso A; Koch H; Haberbosch W; Fellin R; Postiglione A; Augustin J
    Monogr Atheroscler; 1986; 14():135-9. PubMed ID: 3736552
    [No Abstract]   [Full Text] [Related]  

  • 29. Variations in plasma apolipoprotein C-III levels are strong correlates of the triglyceride response to a high-monounsaturated fatty acid diet and a high-carbohydrate diet.
    Archer WR; Desroches S; Lamarche B; Dériaz O; Landry N; Fontaine-Bisson B; Bergeron J; Couture P; Bergeron N
    Metabolism; 2005 Oct; 54(10):1390-7. PubMed ID: 16154441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum lipids and apolipoproteins AI, B100, CI, CII, and CIII in 142 patients with coronary heart disease].
    Liu BW; Shao MZ; Yuan HJ; Wu ZF; Zhang ZH; Fu MD; Zhang RJ; Fan P
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):119-22. PubMed ID: 2512245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma lipoprotein pattern and decreased platelet function in type V hyperlipoproteinemia.
    Aviram M; Brook JG
    Isr J Med Sci; 1985 Nov; 21(11):898-904. PubMed ID: 4077486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum lipids and apolipoproteins AI, B100, CI and CII in patients with apoplexy].
    Liu BW; Zhang ZH; Wu ZF; Fu MD; Zhang RJ; Fan P; Zhang P; Hu CH; Luo ZM; She LM
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Mar; 20(1):9-12. PubMed ID: 2507441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of triglyceride-rich lipoproteins in progression of atherosclerosis.
    Havel RJ
    Circulation; 1990 Feb; 81(2):694-6. PubMed ID: 2297871
    [No Abstract]   [Full Text] [Related]  

  • 35. Concentrations of apoprotein CII, CIII, and E in total serum and in the apoprotein B-containing lipoproteins, determined by a new enzyme-linked immunosorbent assay.
    Alsayed N; Rebourcet R; Chapman J
    Clin Chem; 1990 Dec; 36(12):2047-52. PubMed ID: 2253344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relation of serum apolipoprotein B100 levels to lipids and apolipoproteins A I, A II, C II, C III and E levels in the middle and old age normal males in Chengdu area].
    Wu Z; Liu B; Liu Y; Fang D; Zhang R
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Mar; 28(1):14-7. PubMed ID: 10684054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of apolipoprotein C-III in serum by a noncompetitive immunoenzymometric assay.
    Parsy D; Clavey V; Fievet C; Kora I; Duriez P; Fruchart JC
    Clin Chem; 1985 Oct; 31(10):1632-5. PubMed ID: 3899407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative determination of human apolipoprotein C-III by electroimmunoassay.
    Curry MD; McConathy WJ; Fesmire JD; Alaupovic P
    Biochim Biophys Acta; 1980 Mar; 617(3):503-13. PubMed ID: 7370291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive enzyme-linked immunosorbent assay (ELISA) for the quantitation of apolipoprotein A-I using a monoclonal antibody.
    Bojanovski M; Gregg RE; Wilson DM; Brewer HB
    Clin Chim Acta; 1988 Dec; 178(2):159-69. PubMed ID: 3149556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.